Monoclonal Antibody to Interleukin 8 Receptor Beta (IL8Rb)
CD182; CDw128b; IL8R-B; IL8-RB; CMKAR2; CXCR2; IL8R2; C-X-C chemokine receptor type 2; GRO/MGSA receptor; High affinity interleukin-8 receptor B
- Product No.MAC006Hu22
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceMonoclonal antibody preparation
- HostMouse
- Potency (Clone Number)C3
- Ig Isotype IgG1 Kappa
- PurificationProtein A + Protein G affinity chromatography
- LabelNone
- Immunogen RPC006Hu01-Recombinant Interleukin 8 Receptor Beta (IL8Rb)
- Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
- TraitsLiquid
- Concentration1mg/mL
- Organism Species MoreRattus norvegicus (Rat)
- ApplicationsWB; ICC/IF
 If the antibody is used in flow cytometry, please check FCM antibodies.
- DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
- FOB
    
                                    US$ 114 
            
                
                        US$ 266 
                                        US$ 380 
                                        US$ 950 
                                        US$ 3800 
                            
 For more details, please contact local distributors!
SPECIFITY
The antibody is a mouse monoclonal antibody raised against IL8Rb. It has been selected for its ability to recognize IL8Rb in immunohistochemical staining and western blotting.
USAGE
        Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.    
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- 
                     Antibody Labeling Customized Service Antibody Labeling Customized Service
- 
                     Protein A/G Purification Column Protein A/G Purification Column
- 
                     Staining Solution for Cells and Tissue Staining Solution for Cells and Tissue
- 
                     Positive Control  for Antibody Positive Control  for Antibody
- 
                     Tissue/Sections Customized Service Tissue/Sections Customized Service
- 
                     Phosphorylated Antibody Customized Service Phosphorylated Antibody Customized Service
- 
                     Western Blot (WB) Experiment Service Western Blot (WB) Experiment Service
- 
                     Immunohistochemistry (IHC) Experiment Service Immunohistochemistry (IHC) Experiment Service
- 
                     Immunocytochemistry (ICC) Experiment Service Immunocytochemistry (ICC) Experiment Service
- 
                     Flow Cytometry (FCM) Experiment Service Flow Cytometry (FCM) Experiment Service
- 
                     Immunoprecipitation (IP) Experiment Service Immunoprecipitation (IP) Experiment Service
- 
                     Immunofluorescence (IF) Experiment Service Immunofluorescence (IF) Experiment Service
- 
                     Buffer Buffer
- 
                     DAB Chromogen Kit DAB Chromogen Kit
- 
                     SABC Kit SABC Kit
- 
                     Long-arm Biotin Labeling Kit Long-arm Biotin Labeling Kit
- 
                     Real Time PCR Experimental Service Real Time PCR Experimental Service
| Magazine | Citations | 
| Theranostics | Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles. pubmed:28900508 | 
| Scientific Reports | Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes Pubmed: 30679689 | 
| Pathogenic Functions of Tumor Necrosis Factor Receptor-associated Factor 6 Signaling following Traumatic Brain Injury | |
| The neuroprotection of hyperbaric oxygen therapy against traumatic brain injury via NF-¦ÊB/MAPKs-CXCL1 signaling pathway | 
 
         
 
                             
                            

 
    